This week, there are 8 drugs in the patent and exclusivity list. They are: - AZURITY PHARMACEUTICALS INC's EDARBI, containing active ingredient AZILSARTAN KAMEDOXOMIL - ABBVIE INC's TRILIPIX, containing active ingredient CHOLINE FENOFIBRATE - AZURITY PHARMACEUTICALS INC's EDARBYCLOR, containing active ingredient AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE - TEVA NEUROSCIENCE INC's UZEDY, containing active ingredient RISPERIDONE - TEVA PHARMACEUTICAL INDUSTRIES LTD's AIRDUO RESPICLICK, containing active ingredient FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE - BLUEPRINT MEDICINES CORP's AYVAKIT, containing active ingredient AVAPRITINIB - BOEHRINGER INGELHEIM's GILOTRIF, containing active ingredient AFATINIB DIMALEATE - CEPHALON INC's TRISENOX, containing active ingredient ARSENIC TRIOXIDE Read More

This week, there is 1 drug in the patent and exclusivity list. It is: - BAUSCH AND LOMB INC's VYZULTA, containing active ingredient LATANOPROSTENE BUNOD Read More

This week, there are 4 drugs in the patent and exclusivity list. They are: - STEMLINE THERAPEUTICS INC's ORSERDU, containing active ingredient ELACESTRANT DIHYDROCHLORIDE - ABBVIE INC's UBRELVY, containing active ingredient UBROGEPANT - TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC's AUSTEDO, containing active ingredient DEUTETRABENAZINE - OTSUKA PHARMACEUTICAL CO LTD's REXULTI, containing active ingredient BREXPIPRAZOLE Read More

This week, there are 16 drugs in the patent and exclusivity list. They are: - UNITED THERAPEUTICS CORP's REMODULIN, containing active ingredient TREPROSTINIL - VALINOR PHARMA LLC's MOVANTIK, containing active ingredient NALOXEGOL OXALATE - OTSUKA PHARMACEUTICAL CO LTD's ABILIFY, containing active ingredient ARIPIPRAZOLE - INTRA-CELLULAR THERAPIES INC's CAPLYTA, containing active ingredient LUMATEPERONE TOSYLATE - PFIZER INC's TOVIAZ, containing active ingredient FESOTERODINE FUMARATE - CUBIST PHARMACEUTICALS LLC's ZERBAXA, containing active ingredient CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM - EISAI INC's LENVIMA, containing active ingredient LENVATINIB MESYLATE - PF PRISM CV's BOSULIF, containing active ingredient BOSUTINIB MONOHYDRATE - AMGEN INC's OTEZLA, containing active ingredient APREMILAST Read More

This week, there are 9 drugs in the patent and exclusivity list. They are: - SANDOZ INC's HYCAMTIN, containing active ingredient TOPOTECAN HYDROCHLORIDE - MERCK SHARP AND DOHME LLC A SUB OF MERCK AND CO INC's ZEPATIER, containing active ingredient ELBASVIR; GRAZOPREVIR - NOVARTIS PHARMACEUTICALS CORP's KISQALI FEMARA CO-PACK (COPACKAGED), containing active ingredient LETROZOLE; RIBOCICLIB SUCCINATE - NOVARTIS PHARMACEUTICALS CORP's KISQALI, containing active ingredient RIBOCICLIB SUCCINATE - SAREPTA THERAPEUTICS INC's VYONDYS 53, containing active ingredient GOLODIRSEN - ABBVIE INC's RINVOQ, containing active ingredient UPADACITINIB - PFIZER INC's XELJANZ XR, containing active ingredient TOFACITINIB CITRATE - PF PRISM CV's XELJANZ, containing active ingredient TOFACITINIB CITRATE - CALLIDITAS THERAPEUTICS AB's TARPEYO, containing active ingredient BUDESONIDE Read More

This week, there are 1 drug in the patent and exclusivity list. It is: - ORGANON LLC's XACIATO, containing active ingredient CLINDAMYCIN PHOSPHATE Read More

This week, there are 3 drugs in the patent and exclusivity list. They are: - ABBVIE INC's ACULAR LS, containing active ingredient KETOROLAC TROMETHAMINE - FRESENIUS KABI USA LLC's DIPRIVAN, containing active ingredient PROPOFOL - GLOBAL BLOOD THERAPEUTICS INC's OXBRYTA, containing active ingredient VOXELOTOR Read More

This week, there are 8 drugs in the patent and exclusivity list. They are: - KALEO INC's AUVI-Q, containing active ingredient EPINEPHRINE - NOVO NORDISK INC's VICTOZA, containing active ingredient LIRAGLUTIDE - NOVO NORDISK INC's SAXENDA, containing active ingredient LIRAGLUTIDE - BRISTOL MYERS SQUIBB's REVLIMID, containing active ingredient LENALIDOMIDE - CUMBERLAND PHARMACEUTICALS INC's CALDOLOR, containing active ingredient IBUPROFEN - AMERICAN REGENT INC's INJECTAFER, containing active ingredient FERRIC CARBOXYMALTOSE - ALNYLAM PHARMACEUTICALS INC's GIVLAARI, containing active ingredient GIVOSIRAN SODIUM - AADI BIOSCIENCE INC's FYARRO, containing active ingredient SIROLIMUS Read More

This week, there are 9 drugs in the patent and exclusivity list. They are: - JANSSEN PHARMACEUTICALS INC's XARELTO, containing active ingredient RIVAROXABAN - KYOWA KIRIN INC's NOURIANZ, containing active ingredient ISTRADEFYLLINE - SEAGEN INC's TUKYSA, containing active ingredient TUCATINIB - VANDA PHARMACEUTICALS INC's PONVORY, containing active ingredient PONESIMOD - AVEO PHARMACEUTICALS INC's FOTIVDA, containing active ingredient TIVOZANIB HYDROCHLORIDE - BIOMARIN PHARMACEUTICAL INC's KUVAN, containing active ingredient SAPROPTERIN DIHYDROCHLORIDE - PROVENSIS LTD's VARITHENA, containing active ingredient POLIDOCANOL - BEIGENE USA INC's BRUKINSA, containing active ingredient ZANUBRUTINIB - SHIONOGI INC's FETROJA, containing active ingredient CEFIDEROCOL SULFATE TOSYLATE Read More